European CHMP recommends approval of zanamivir solution for infusion (Dectova) for the treatment of complicated and potentially life-threatening influenza

This opinion summary advises that it will be available as a 10 mg/ml solution for infusion for the treatment of complicated and potentially life-threatening influenza A or B virus infection in patients aged ≥6 months when other anti-virals, including inhaled zanamivir, are not suitable for the patient.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news

Related Links:

Authors: Ventura CG, Roque FL, Sousa IQ, Lobo RD, Luders C Abstract INTRODUCTION: Chronic hemodialysis (HD) patients are considered to be at high risk for infection. Here, we describe the clinical outcomes of chronic HD patients with influenza A (H1N1) infection and the strategies adopted to control an outbreak of influenza A in a dialysis unit. METHODS: Among a total of 62 chronic HD patients, H1N1 infection was identified in 12 (19.4%). Of the 32 staff members, four (12.5%) were found to be infected with the H1N1 virus. Outcomes included symptoms at presentation, comorbidities, occurrence of hypoxemia, hospit...
Source: Jornal Brasileiro de Nefrologia - Category: Urology & Nephrology Tags: J Bras Nefrol Source Type: research
Please don't get me wrong. I've seen other people try to put our present crisis in context, or discuss the costs vs. the benefits of certain actions, and be widely condemned for insensitivity or even sociopathy. I remember after the 9/11 attack, when people who tried to explain the motivations or sociological origins of Al Qaeda and similar movements faced the same sort of criticism. You weren't allowed to think about the problem, people weren't ready for any sort of moral confusion. In what I am about to say, I am not arguing against saving lives, on the contrary. I'm just trying to explain something about where we are in...
Source: Stayin' Alive - Category: American Health Source Type: blogs
Influenza cases confirmed in clinical laboratories fell recently, but healthcare visits for influenza-like illness continue to rise, according to the Centers for Disease Control and Prevention.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news
Abbott’s new ID NOW COVID-19 test, which earned emergency use authorization (EUA) from FDA last week, was highlighted during President Donald Trump’s COVID-19 taskforce press briefing on March 30. FDA Commissioner Stephen Hahn spoke about the rapid approval of Abbott’s point-of-care test for COVID-19. “Normally these tests take months to develop,” Hahn noted during the briefing. “I was on the phone today with the Abbott CEO who told me this is normally a 9- to 12-month approach to developing a point-of-care test. The...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Source Type: news
Just because a coronavirus test says you don ’t have the virus doesn’t mean you aren’t infected — or infectious.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Tests (Medical) Coronavirus (2019-nCoV) Quarantines Antibiotics Influenza Hygiene and Cleanliness Source Type: news
Emergent BioSolutions Inc. has inked another deal with fellow Gaithersburg biotech Novavax Inc. — this time, for its seasonal flu vaccine. The agreement means Emergent (NYSE: EBS) will develop and manufacture NanoFlu, the influenza vaccine which Novavax (NASDAQ: NVAX) successfully pushed through phase 3 clinical trials in a critical win announced March 24. It also comes just a few weeks aft er the two companies teamed up to get a COVID-19 vaccine to the clinic in the race against the pandemic.…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
With a deadly coronavirus epidemic creeping northward and the nearest hospital 230 miles away, Galen Gilbert, First Chief of Arctic Village, Alaska, knew his 200-person town could not afford to take any chances. A single case of COVID-19 could lead to the virus quickly spreading around the tight-knit community, but anybody who needed hospitalization would likely face an overstretched medevac system. As national infection rates rose, the 32-year-old leader and his village made an agonizing decision: rather than risk a potentially devastating outbreak, Arctic Village cut itself off almost entirely from the outside world. &ld...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news
We live in unprecedented modern times experiencing how an outbreak of a particular viral disease, COVID-19, caused by SARS-CoV-2, also commonly referred to as the Coronavirus, is disrupting societies and personal lives. The virus is likely to spread to most, if not all, countries, illustrating the interconnectedness of the world. At the time of writing, Italy and Spain have become the epicenters in terms of fatalities in Europe, whereas the United States has recorded the most diagnosed cases worldwide. While many national measures to contain, suppress, mitigate, or delay the spread of the virus are being taken, there is gr...
Source: Scandinavian Journal of Work, Environment and Health - Category: Occupational Health Tags: Editorial Source Type: research
“ Living the Wheat Belly and Undoctored lifestyle will not rid our lives of all adversity. But it can make you stronger, more optimistic, and resilient. Here is Lonnie and Carrie’s story: “One year ago today, my life changed in unthinkable ways. I discovered the Wheat Belly 10-Day Grain Detox book and read it during my kids’ spring break. I had dabbled in the ‘paleo’ diet world a bit over the last five years with inconsistent success and had some idea about how good I felt when eliminating grains… “But the protocols in this book seemed to go further then just diet, like addr...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Open Depression grain-free Inflammation undoctored Weight Loss wheat belly Source Type: blogs
Condition:   Influenza Interventions:   Drug: Baloxavir;   Drug: Placebos Sponsor:   Bassett Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Health | Influenza | Relenza | Zanamivir